Private clinics’ peddling of unproven stem cell treatments is unsafe and unethical – Medical Xpress
Medical Xpress |
Private clinics’ peddling of unproven stem cell treatments is unsafe and unethical
Medical Xpress Stem cell science is an area of medical research that continues to offer great promise. But as this week’s paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, are exploiting … Brothers Michael and Alex Wood share a stem cell bond at the Stadium StompThe Advertiser Standardized Stem CellsHuffPost Stem cell therapies breaking barriersGuardian (blog) EurekAlert (press release) –Business Wire (press release) –eHealth Magazine | Elets all 18 news articles » |
pharmaphorum |
Oxford BioMedica signs $100m CAR–T deal with Novartis
pharmaphorum The deal represents a major financial boost for the UK biotech firm, which provides bioprocessing services for third parties as well as advancing its own gene and cell therapies. Novartis’ CTL019 could be the first groundbreaking CAR–T to gain approval … Oxford BioMedica and Novartis build on supply deal as CAR–T medication nears finish lineFiercePharma Oxford BioMedica signs major supply deal with NovartisPharmaTimes Oxford BioMedica, Novartis link up on CAR–T drug productionBioPharma Dive |
|
Better than CRISPR? LASSO Cloning ropes in Long-Read DNA
Labiotech.eu (blog) After CRISPR, there’s a new genetic technique with a tongue-in-cheek name in town: LASSO cloning, a method to sequence long DNA fragments. |